Biogen plans to launch a multi-year, observational trial later this year to monitor data from Apple Watches and iPhones to identify digital biomarkers of mild cognitive impairment.

Researchers have suggested that such biomarkers may be helpful for predicting risk of Alzheimer’s disease and other dementias. Ultimately, this may also improve the use of early lifestyle and therapeutic intervention efforts to reduce the progression of cognitive decline.